Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

31 trials with published results (13%)

Research Maturity

166 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.9%

7 terminated out of 240 trials

Success Rate

96.0%

+9.4% vs benchmark

Late-Stage Pipeline

12%

28 trials in Phase 3/4

Results Transparency

19%

31 of 166 completed with results

Key Signals

31 with results96% success

Data Visualizations

Phase Distribution

182Total
Not Applicable (129)
Early P 1 (2)
P 1 (12)
P 2 (11)
P 3 (20)
P 4 (8)

Trial Status

Completed166
Unknown22
Recruiting20
Active Not Recruiting12
Terminated7
Withdrawn7

Trial Success Rate

96.0%

Benchmark: 86.5%

Based on 166 completed trials

Clinical Trials (240)

Showing 20 of 20 trials
NCT05824234Not ApplicableRecruitingPrimary

Implementation of REFOCUS Training Program in Mental Health Services

NCT07641244Not ApplicableRecruiting

Experimental Evidence of the Impact of Parental Income on Child Mental Health and Neuroimmune Function

NCT07643714Not ApplicableCompleted

Effects of ACT-Based Psychoeducation on Caregivers of Individuals With Mental Disorders

NCT05508789Phase 3Active Not Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT07387757Not ApplicableCompletedPrimary

Exergames in Mental Health

NCT05854160Not ApplicableRecruiting

Stimulation-Induced Changes in Fronto-Limbic Network

NCT07581158Not ApplicableNot Yet Recruiting

Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa

NCT03887559Not ApplicableRecruiting

Group-based Stabilization and Skill Training for Patients With Lasting Posttraumatic Reactions in Mental Health Care

NCT05989646Not ApplicableRecruiting

Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children

NCT06511908Phase 2Recruiting

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

NCT07466875Not ApplicableRecruiting

Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients

NCT06810076Not ApplicableActive Not Recruiting

Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care

NCT05318976Phase 2Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

NCT03353805CompletedPrimary

Hospital Cohort Survey of Public Health Post-attack of July 14, 2016

NCT02836080Not ApplicableActive Not RecruitingPrimary

Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)

NCT06580860RecruitingPrimary

Psychiatric Multi-omics and Neuroimaging Project

NCT07446218Not ApplicableNot Yet RecruitingPrimary

Pharmacist-led Interventions in Psychiatric Patients

NCT07443033Not Yet Recruiting

Psychosocial Factors in Dual Diagnosis in a General Hospital

NCT05522387Phase 2Terminated

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

NCT06387290Phase 3Recruiting

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

Scroll to load more

Research Network

Activity Timeline